Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07711093 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Eso-SPONGE for Treating Leaks After Upper Gastrointestinal Surgery

Study acronym: DRAIN Upper
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-12
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoints added 0 → 2 primary endpoints
See other at-risk trials from Boston Scientific Corporation

Amendment history

2026-09-19
critical
Trial status changed: Withheld → Not Yet Recruiting
Phase changed: not specified → not applicable
Primary endpoint(s) modified
Enrollment changed: None → 74
Sponsor changed: [Redacted] → Boston Scientific Corporation+19 characters
Was[Redacted]
NowBoston Scientific Corporation
Trial arms changed: 0 → 1
Interventions modified
2026-09-05
minor
3 amendments v1-v3
3 re-verifications since 2026-07-21, no change to tracked fields
2026-07-14
minor
Original filing
To evaluate the safety and effectiveness of sponge-based Endoscopic Vacuum Therapy (EVT) using Eso-SPONGE for the treatment of anastomotic leaks in the upper gastrointestinal tract in a prospective multi-center study.
Trial Details
NCT Number NCT07711093
Lead Sponsor Boston Scientific Corporation
Conditions Anastomotic Leaks
Enrollment 74 participants
Start Date 2026-12
Primary Completion 2028-12 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2026-09-18